Clinical Trial Update: Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer

View source ↗

Summary

The trial evaluating diffuse optical tomography to monitor response to neoadjuvant chemotherapy in breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Breast Neoplasms | Status: TERMINATED